Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matthew K Tollefson

The CD4+/CD14+HLA-DRlo/neg Ratio as a Prognostic Biomarker in Cancer Patients

Journal for ImmunoTherapy of Cancer

English

Mp80-05 Nerve Sparing During Radical Prostatectomy Does Not Adversely Impact Margin Status, Complications, or Long-Term Oncologic Outcomes

Journal of Urology

Urology

2016

English

Related publications

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International

English

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

British Journal of Cancer

Cancer Research

Oncology

2011

English

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

English

Reply to Neutrophil-To-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710

English

Identification of a Three miRNA Signature as a Novel Potential Prognostic Biomarker in Patients With Blaader Cancer

Oncotarget

Oncology

2017

English

MicroRNA-Gene Association as a Prognostic Biomarker in Cancer Exposes Disease Mechanisms

PLoS Computational Biology

Molecular Neuroscience

English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer

Oncology

2017

English

Prognostic Value of Aspartate Aminotransferase to Platelet Ratio Index as a Noninvasive Biomarker in Patients With Hepatocellular Carcinoma: A Meta-Analysis

Cancer Management and Research

Oncology

2018

English

Analysis of Interleukin-13 Receptor Alpha2 Expression as a Prognostic Biomarker in Surgically Resected Pancreatic Cancer Patients

Journal for ImmunoTherapy of Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matthew K Tollefson

The CD4+/CD14+HLA-DRlo/neg Ratio as a Prognostic Biomarker in Cancer Patients

Mp80-05 Nerve Sparing During Radical Prostatectomy Does Not Adversely Impact Margin Status, Complications, or Long-Term Oncologic Outcomes

Related publications

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

Disseminated Tumour Cells as a Prognostic Biomarker in Colorectal Cancer

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

Reply to Neutrophil-To-Lymphocyte Ratio as a Bladder Cancer Biomarker: Assessing Prognostic and Predictive Value in SWOG 8710

Identification of a Three miRNA Signature as a Novel Potential Prognostic Biomarker in Patients With Blaader Cancer

MicroRNA-Gene Association as a Prognostic Biomarker in Cancer Exposes Disease Mechanisms

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Prognostic Value of Aspartate Aminotransferase to Platelet Ratio Index as a Noninvasive Biomarker in Patients With Hepatocellular Carcinoma: A Meta-Analysis

Analysis of Interleukin-13 Receptor Alpha2 Expression as a Prognostic Biomarker in Surgically Resected Pancreatic Cancer Patients